Health Care Sector

TM Capital has developed in-depth health care sector expertise by completing the many transactions listed below for clients who are leaders across a range of health care disciplines.

MedTech Completes Recapitalization TM Capital assisted The MedTech Group in completing a recapitalization with KRG Capital Partners to accelerate growth and provide shareholder liquidity Review Transaction	Dinex Acquired by Carlisle Companies TM Capital advised Dinex Holdings, a provider of specialty foodservice products, in its sale to Carlisle Companies (NYSE), a $2 billion diversified global manufacturing company Review Transaction
Immucor to Acquire BioArray Solutions TM Capital is advising Immucor, Inc. (NASDAQ) on its pending $117 million acquisition of BioArray Solutions Ltd. Review Transaction	Immucor Forms Joint Venture with Kainos TM Capital assisted Immucor, Inc. (NASDAQ) in forming a joint venture for distribution of Immucor's products in Japan with Kainos Laboratories, Inc. Review Transaction
Immucor Acquires Gamma Biologicals TM Capital assisted Immucor, Inc. (NASDAQ) in completing the $30 million acquisition of Gamma Biologicals, Inc. (AMEX) via a cash tender offer Review Transaction	SteriGenics Acquired by IBA TM Capital completed the sale of SteriGenics International, Inc. (NASDAQ) to Ion Beam Applications s.a. of Belgium for $214 million in cash Review Transaction
SteriGenics Acquires Nicolet from Thermo TM Capital assisted SteriGenics International, Inc. (NASDAQ) in acquiring Nicolet Electron Services from the Thermo-Electron Group (NYSE) Review Transaction	Portland Professional Acquired by NMHC TM Capital completed the sale of Portland Professional Pharmacy to National Medical Health Card Systems, Inc. (NASDAQ) Review Transaction
Jensen Completes Recapitalization TM Capital assisted Jensen Industries Inc. in completing a recapitalization transaction Review Transaction	Heico Sells Meditek to U.S. Diagnostic Labs TM Capital completed the $23 million sale by Heico Corporation (NYSE) of its Meditek Health division to U.S. Diagnostic Labs, Inc. (NASDAQ) Review Transaction
Medical Diagnostics Acquired by ANMR TM Capital completed the $29 million sale of Medical Diagnostics, Inc. (NASDAQ) to Advanced NMR Systems Inc. (NASDAQ) following an unsolicited tender offer by Raytel Medical Corp. (NASDAQ) Review Transaction	Medcom Acquired by Quintiles TM Capital completed the sale of Medcom, Inc. to Quintiles Transnational Corp. (NASDAQ) Review Transaction
Armstrong Pharma Acquired by Medeva TM Capital advised Armstrong Pharmaceuticals, Inc. (NASDAQ) in completing its $52 million stock swap merger with Medeva plc (LSE) Review Transaction	International Murex Completes Financing TM Capital arranged $15 million of senior debt financing for International Murex Technologies Corporation (NASDAQ) Review Transaction
Immucor Acquires Division of Biopool TM Capital assisted Immucor, Inc. (NASDAQ) in the acquisition of the BCA division of Biopool International, Inc. (NASDAQ) Review Transaction	Immucor Completes Debt Restructuring TM Capital assisted Immucor, Inc. (NASDAQ) in restructuring $42 million of senior indebtedness Review Transaction
Immucor Board of Directors Re-Elected TM Capital advised the Board of Directors of Immucor, Inc.(NASDAQ) in connection with a proxy contest in which all of Immucor's directors were successfully re-elected Review Transaction	Immucor Goodwill Valuation Analysis TM Capital provided Immucor, Inc. (NASDAQ) with an analysis of goodwill balances for potential impairment pursuant to FAS 142 Review Transaction
SteriGenics Acquires Irradiation Industries TM Capital assisted SteriGenics International, Inc. (NASDAQ) in the strategic acquisition of Irradiation Industries, Inc. Review Transaction	SteriGenics Int'l Acquires RTI TM Capital assisted SteriGenics International, Inc. (NASDAQ) in acquiring the business and assets of RTI, Inc. Review Transaction
BioLok Acquired by Healthpoint Capital TM Capital rendered a fairness opinion to the Board of Directors of BioLok International Inc. (OTC) with respect to the sale of BioLok to Healthpoint Capital Review Transaction